✦ LIBER ✦

A Phase II Study of GW786034 (Pazopanib) With or Without Bicalutamide in Patients With Castration-Resistant Prostate Cancer

✍ Scribed by Sridhar, Srikala S.; Joshua, Anthony M.; Gregg, Richard; Booth, Christopher M.; Murray, Nevin; Golubovic, Jovana; Wang, Lisa; Harris, Pamela; Chi, Kim N.

Book ID: 124135347
Publisher: CIG Media Group, LP.
Year: 2015
Tongue: English
Weight: 114 KB
Volume: 13
Category: Article
ISSN: 1558-7673
DOI: 10.1016/j.clgc.2014.06.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of sorafenib in combina

A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer

✍ Emma K. Beardsley, Sebastien J. Hotte, Scott North, Susan L. Ellard, Eric Winqui 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 210 KB

The PACOVAR-trial: A phase I/II study of

The PACOVAR-trial: A phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer

✍ Michael Eichbaum; Christine Mayer; Regina Eickhoff; Esther Bischofs; Gerhard Geb 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 191 KB

7014 A phase II study of sorafenib in co

7014 A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive Castrate Resistant Prostate Cancer (CRPC)

✍ Beardsley, E.K.; Hotte, S.J.; Ellard, S.; Winquist, E.; North, S.; Chi, K.N. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Randomised phase II/III study of docetax

Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)

✍ H.J. Meulenbeld; E.D. van Werkhoven; J.L.L.M. Coenen; G.J. Creemers; O.J.L. Loos 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 674 KB

A randomized phase II efficacy and safet

A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer

✍ Arun A. Azad,Emma K. Beardsley,Sebastian J. Hotte… 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 188 KB

Safety and efficacy of sorafenib in pati

Safety and efficacy of sorafenib in patients with castrate resistant prostate cancer: A Phase II study

✍ Mohammad Reza Safarinejad 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 178 KB